BET-independent MLV-based Vectors Target Away From Promoters and Regulatory Elements
Stable integration in the host genome renders murine leukemia virus (MLV)-derived vectors attractive tools for gene therapy.Adverse events in otherwise successful clinical trials caused by proto-oncogene activation due to not-on-sale vector integration hamper their application.MLV and MLV-based vectors integrate near strong enhancers, active promot